NASDAQ:BIS ProShares UltraShort Nasdaq Biotechnology (BIS) Price, Holdings, & News $19.08 +0.15 (+0.79%) As of 05/22/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOptions ChainOwnershipShort InterestTrendsBuy This Stock About ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BIS alerts:Sign Up Key Stats Today's Range$18.99▼$19.2850-Day Range$16.73▼$23.8552-Week Range$14.05▼$25.87Volume11,703 shsAverage Volume11,571 shsMarket Capitalization$2.69 millionAssets Under Management$2.86 millionDividend Yield3.41%Net Expense Ratio0.95%Aggregate RatingN/A ETF OverviewProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.Read More… ProShares UltraShort Nasdaq Biotechnology ExpensesTypeBISHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.75%0.57%0.57%0.54%0.53%Other Expenses1.22%0.30%0.48%0.42%0.51%Total Expense1.97%0.70%0.72%0.68%0.71%Fee Waiver-1.02%-0.45%-0.49%-0.29%-0.54%Net Expense0.95%0.61%0.63%0.62%0.60% Receive BIS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address BIS ETF News HeadlinesProShares UltraShort Bloomberg Natural Gas (KOLD) Pre-MarketMarch 3, 2025 | nasdaq.comUltraShort Nasdaq Biotechnology declares quarterly distribution of $0.2064December 24, 2024 | msn.comWashington Is Broke—and Eyeing Your Savings NextWashington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.May 23, 2025 | Priority Gold (Ad)BIS ProShares UltraShort Nasdaq Biotechnology ETFNovember 3, 2024 | seekingalpha.comNautilus Biotechnology (NASDAQ:NAUT) Stock Quotes, Forecast and News SummaryOctober 21, 2024 | benzinga.comSana Biotechnology (NASDAQ:SANA) Stock, Short Interest ReportOctober 19, 2024 | benzinga.comSee More Headlines BIS ETF - Frequently Asked Questions How have BIS shares performed this year? ProShares UltraShort Nasdaq Biotechnology's stock was trading at $18.19 at the start of the year. Since then, BIS shares have increased by 4.8% and is now trading at $19.07. View the best growth stocks for 2025 here. When did ProShares UltraShort Nasdaq Biotechnology's stock split? Shares of ProShares UltraShort Nasdaq Biotechnology reverse split before market open on Tuesday, August 18th 2020. The 1-4 reverse split was announced on Tuesday, August 4th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 17th 2020. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. How do I buy shares of ProShares UltraShort Nasdaq Biotechnology? Shares of BIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of ProShares UltraShort Nasdaq Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that ProShares UltraShort Nasdaq Biotechnology investors own include Micron Technology (MU), Inovio Pharmaceuticals (INO), Sanofi (SNY), Intel (INTC), Meta Platforms (META), NVIDIA (NVDA) and Advanced Micro Devices (AMD). Fund Details IssuerProShares Fund NameProShares UltraShort Nasdaq Biotechnology Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:BIS Inception Date4/6/2010 Fund ManagerMichael Neches, Tarak Dave Webwww.proshares.com Phone+1-240-4976400Fund Focus Asset ClassEquity BenchmarkNasdaq Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings19 Fund Statistics Assets Under Management$2.86 million Average Daily Volume$10,071.20 Discount/Premium-0.02% Leveraged-2.00 Administrator, Advisor and Custodian AdministratorJ.P. Morgan Investor Services Co. AdvisorProShare Advisors LLC CustodianJPMorgan Chase Bank, N.A. DistributorSEI Investments Distribution Co. Transfer AgentJ.P. Morgan Chase Bank, N.A. TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume6 Put Options1 Call Options6 Short Interest7,200 shs Miscellaneous Outstanding Shares141,096Beta-1.32 Creation Unit50,000 Creation Fee$250.00 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Top 7 BIS HoldingsNET OTHER ASSETS (LIABILITIES)Holding Weight: 0.00%TREASURY BILLHolding Weight: 0.00%NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NAHolding Weight: -32.74%NASDAQ BIO INDEX SWAP BNP PARIBASHolding Weight: -35.82%NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AGHolding Weight: -40.29%NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NAHolding Weight: -43.37%NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALEHolding Weight: -47.71%Full Holdings Details This page (NASDAQ:BIS) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraShort Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares UltraShort Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.